Gene Symbol | Gene ID | Gene Info |
---|---|---|
POU3F2
|
ENSG00000184486.7 | POU class 3 homeobox 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_99276322_99276473 | POU3F2 | 6183 | 0.329626 | 0.68 | 4.2e-02 | Click! |
chr6_99275444_99275595 | POU3F2 | 7061 | 0.323405 | -0.57 | 1.1e-01 | Click! |
chr6_99296594_99296745 | POU3F2 | 14089 | 0.291827 | -0.56 | 1.2e-01 | Click! |
chr6_99296388_99296556 | POU3F2 | 13892 | 0.292446 | -0.52 | 1.5e-01 | Click! |
chr6_99296022_99296248 | POU3F2 | 13555 | 0.293505 | -0.52 | 1.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr4_15769645_15769984 | 1.31 |
CD38 |
CD38 molecule |
10087 |
0.23 |
chr17_47896409_47896901 | 1.08 |
RP11-304F15.3 |
|
26617 |
0.12 |
chr19_16478953_16479699 | 1.07 |
EPS15L1 |
epidermal growth factor receptor pathway substrate 15-like 1 |
6562 |
0.16 |
chr5_110570725_110571085 | 1.04 |
CAMK4 |
calcium/calmodulin-dependent protein kinase IV |
11121 |
0.22 |
chr14_61847122_61847471 | 0.93 |
PRKCH |
protein kinase C, eta |
10116 |
0.24 |
chr8_129566610_129566901 | 0.92 |
ENSG00000221351 |
. |
265285 |
0.02 |
chr8_124099579_124099969 | 0.89 |
TBC1D31 |
TBC1 domain family, member 31 |
6127 |
0.18 |
chr14_90107458_90107875 | 0.89 |
ENSG00000252655 |
. |
9581 |
0.14 |
chr8_126950940_126951091 | 0.89 |
ENSG00000206695 |
. |
37820 |
0.23 |
chr5_156606721_156606948 | 0.89 |
ITK |
IL2-inducible T-cell kinase |
1003 |
0.44 |
chr6_143252390_143252629 | 0.87 |
HIVEP2 |
human immunodeficiency virus type I enhancer binding protein 2 |
13829 |
0.25 |
chr5_130728834_130729229 | 0.86 |
CDC42SE2 |
CDC42 small effector 2 |
7732 |
0.31 |
chr6_112184533_112184813 | 0.86 |
FYN |
FYN oncogene related to SRC, FGR, YES |
5087 |
0.32 |
chr2_235371267_235371613 | 0.85 |
ARL4C |
ADP-ribosylation factor-like 4C |
33804 |
0.25 |
chr4_184353113_184353349 | 0.83 |
CDKN2AIP |
CDKN2A interacting protein |
12513 |
0.18 |
chr10_14569816_14570147 | 0.83 |
FAM107B |
family with sequence similarity 107, member B |
4728 |
0.27 |
chr12_46285383_46285564 | 0.82 |
ENSG00000265093 |
. |
17661 |
0.21 |
chr18_56361181_56361418 | 0.82 |
RP11-126O1.4 |
|
16453 |
0.15 |
chr22_23165498_23166442 | 0.82 |
ENSG00000207836 |
. |
700 |
0.26 |
chr2_198713002_198713153 | 0.82 |
PLCL1 |
phospholipase C-like 1 |
38095 |
0.18 |
chr8_126946929_126947080 | 0.82 |
ENSG00000206695 |
. |
33809 |
0.24 |
chr14_99652901_99653521 | 0.81 |
AL162151.4 |
|
28458 |
0.21 |
chr20_57732386_57732675 | 0.80 |
ZNF831 |
zinc finger protein 831 |
33545 |
0.19 |
chr1_117296335_117296486 | 0.80 |
CD2 |
CD2 molecule |
597 |
0.78 |
chr15_89168361_89168512 | 0.79 |
AEN |
apoptosis enhancing nuclease |
3835 |
0.18 |
chr6_154563218_154563545 | 0.78 |
IPCEF1 |
interaction protein for cytohesin exchange factors 1 |
4609 |
0.35 |
chr17_46490235_46490470 | 0.78 |
SKAP1 |
src kinase associated phosphoprotein 1 |
17200 |
0.13 |
chr8_41815630_41815821 | 0.78 |
KAT6A |
K(lysine) acetyltransferase 6A |
156 |
0.97 |
chr2_204586779_204587049 | 0.78 |
CD28 |
CD28 molecule |
15498 |
0.22 |
chr5_98241791_98242043 | 0.78 |
ENSG00000222610 |
. |
16482 |
0.19 |
chr15_60877657_60877957 | 0.78 |
RORA |
RAR-related orphan receptor A |
6933 |
0.24 |
chr8_22496270_22496646 | 0.78 |
BIN3 |
bridging integrator 3 |
5859 |
0.12 |
chr15_63964059_63964210 | 0.76 |
RP11-317G6.1 |
|
3211 |
0.25 |
chr1_66818663_66819387 | 0.75 |
PDE4B |
phosphodiesterase 4B, cAMP-specific |
1040 |
0.69 |
chr2_204724953_204725104 | 0.75 |
CTLA4 |
cytotoxic T-lymphocyte-associated protein 4 |
7481 |
0.26 |
chr20_56004615_56004883 | 0.74 |
RP4-800J21.3 |
|
36631 |
0.13 |
chr11_18353889_18354171 | 0.74 |
GTF2H1 |
general transcription factor IIH, polypeptide 1, 62kDa |
5734 |
0.14 |
chr2_42523506_42523974 | 0.74 |
EML4 |
echinoderm microtubule associated protein like 4 |
4653 |
0.29 |
chr12_9909080_9909231 | 0.73 |
CD69 |
CD69 molecule |
4342 |
0.18 |
chr1_24839011_24839397 | 0.73 |
RCAN3 |
RCAN family member 3 |
1606 |
0.35 |
chr1_117359065_117359373 | 0.73 |
CD2 |
CD2 molecule |
62130 |
0.1 |
chr1_168391686_168391980 | 0.73 |
ENSG00000207974 |
. |
47071 |
0.16 |
chr4_148972762_148973133 | 0.72 |
RP11-76G10.1 |
|
94675 |
0.09 |
chr5_61593438_61593771 | 0.72 |
KIF2A |
kinesin heavy chain member 2A |
8385 |
0.28 |
chr16_1610009_1610269 | 0.72 |
LA16c-425C2.1 |
|
20170 |
0.08 |
chr15_26093847_26093998 | 0.71 |
ENSG00000266517 |
. |
50 |
0.98 |
chr6_90943396_90943579 | 0.71 |
BACH2 |
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
62974 |
0.13 |
chr1_114334112_114334428 | 0.71 |
RP5-1073O3.2 |
|
20731 |
0.14 |
chr17_37934637_37934793 | 0.71 |
IKZF3 |
IKAROS family zinc finger 3 (Aiolos) |
237 |
0.9 |
chr8_19284492_19284750 | 0.70 |
SH2D4A |
SH2 domain containing 4A |
107520 |
0.08 |
chr1_100830194_100830345 | 0.70 |
CDC14A |
cell division cycle 14A |
11764 |
0.18 |
chr19_39347476_39347645 | 0.70 |
HNRNPL |
heterogeneous nuclear ribonucleoprotein L |
4582 |
0.08 |
chr2_230716612_230716986 | 0.70 |
TRIP12 |
thyroid hormone receptor interactor 12 |
7199 |
0.21 |
chr21_34084761_34084912 | 0.70 |
SYNJ1 |
synaptojanin 1 |
14370 |
0.15 |
chr10_48533594_48533745 | 0.70 |
GDF10 |
growth differentiation factor 10 |
94693 |
0.07 |
chr2_177669_177835 | 0.69 |
AC079779.7 |
|
19817 |
0.21 |
chr2_204807141_204807405 | 0.69 |
ICOS |
inducible T-cell co-stimulator |
5770 |
0.3 |
chr21_43842200_43842523 | 0.69 |
ENSG00000252619 |
. |
4659 |
0.15 |
chr2_198189379_198189688 | 0.68 |
AC010746.3 |
|
13416 |
0.15 |
chrX_109480438_109480664 | 0.68 |
ENSG00000208883 |
. |
12260 |
0.23 |
chr13_41929345_41929536 | 0.68 |
ENSG00000223280 |
. |
645 |
0.73 |
chr1_110047727_110047978 | 0.68 |
AMIGO1 |
adhesion molecule with Ig-like domain 1 |
4452 |
0.12 |
chr6_36077167_36077664 | 0.68 |
MAPK13 |
mitogen-activated protein kinase 13 |
20683 |
0.16 |
chr17_80085357_80085766 | 0.68 |
CCDC57 |
coiled-coil domain containing 57 |
871 |
0.4 |
chr13_42040879_42041131 | 0.67 |
RGCC |
regulator of cell cycle |
9310 |
0.16 |
chr10_49537749_49537900 | 0.67 |
MAPK8 |
mitogen-activated protein kinase 8 |
22755 |
0.22 |
chr1_90068349_90068631 | 0.67 |
RP11-413E1.4 |
|
26794 |
0.14 |
chr14_103249636_103249863 | 0.67 |
TRAF3 |
TNF receptor-associated factor 3 |
5794 |
0.19 |
chr3_56627315_56627668 | 0.67 |
CCDC66 |
coiled-coil domain containing 66 |
34711 |
0.2 |
chr2_106395941_106396479 | 0.67 |
NCK2 |
NCK adaptor protein 2 |
34022 |
0.21 |
chr4_100766772_100766923 | 0.66 |
DAPP1 |
dual adaptor of phosphotyrosine and 3-phosphoinositides |
28844 |
0.18 |
chr3_136639103_136639532 | 0.66 |
NCK1 |
NCK adaptor protein 1 |
7564 |
0.2 |
chr2_106486812_106486963 | 0.66 |
AC009505.2 |
|
13254 |
0.23 |
chr20_57753276_57753706 | 0.66 |
ZNF831 |
zinc finger protein 831 |
12584 |
0.25 |
chr5_56541889_56542516 | 0.66 |
GPBP1 |
GC-rich promoter binding protein 1 |
32244 |
0.21 |
chr4_77953232_77953464 | 0.66 |
SEPT11 |
septin 11 |
3478 |
0.28 |
chr16_71914316_71914975 | 0.66 |
ZNF821 |
zinc finger protein 821 |
677 |
0.52 |
chr20_39683766_39683943 | 0.66 |
TOP1 |
topoisomerase (DNA) I |
26396 |
0.18 |
chr6_90306124_90306275 | 0.66 |
ANKRD6 |
ankyrin repeat domain 6 |
27487 |
0.15 |
chr8_134066095_134066550 | 0.66 |
SLA |
Src-like-adaptor |
6281 |
0.26 |
chr2_11005512_11005663 | 0.66 |
AC092687.4 |
Uncharacterized protein |
17884 |
0.17 |
chr21_15911267_15911507 | 0.65 |
SAMSN1 |
SAM domain, SH3 domain and nuclear localization signals 1 |
7275 |
0.26 |
chr12_15715155_15715553 | 0.65 |
PTPRO |
protein tyrosine phosphatase, receptor type, O |
16068 |
0.26 |
chr6_160436305_160436759 | 0.65 |
AIRN |
antisense of IGF2R non-protein coding RNA |
7836 |
0.24 |
chrX_40968722_40969014 | 0.65 |
USP9X |
ubiquitin specific peptidase 9, X-linked |
23980 |
0.25 |
chr6_167531770_167531921 | 0.65 |
CCR6 |
chemokine (C-C motif) receptor 6 |
4412 |
0.22 |
chr2_12628882_12629120 | 0.65 |
ENSG00000207183 |
. |
77374 |
0.12 |
chr13_114910310_114910591 | 0.65 |
RASA3 |
RAS p21 protein activator 3 |
12364 |
0.21 |
chr1_172510338_172510489 | 0.65 |
SUCO |
SUN domain containing ossification factor |
8056 |
0.24 |
chr17_1775725_1776037 | 0.65 |
RPA1 |
replication protein A1, 70kDa |
6448 |
0.16 |
chr14_21697616_21697899 | 0.64 |
HNRNPC |
heterogeneous nuclear ribonucleoprotein C (C1/C2) |
1824 |
0.32 |
chr14_52880735_52880886 | 0.64 |
PTGER2 |
prostaglandin E receptor 2 (subtype EP2), 53kDa |
99697 |
0.07 |
chr4_144440272_144440423 | 0.64 |
SMARCA5-AS1 |
SMARCA5 antisense RNA 1 |
4559 |
0.24 |
chr7_150207555_150208051 | 0.64 |
GIMAP7 |
GTPase, IMAP family member 7 |
4115 |
0.23 |
chr1_193448919_193449104 | 0.64 |
ENSG00000252241 |
. |
252063 |
0.02 |
chr20_51678302_51678453 | 0.64 |
ENSG00000252629 |
. |
779 |
0.71 |
chr7_130066201_130066352 | 0.64 |
CEP41 |
centrosomal protein 41kDa |
295 |
0.87 |
chr8_2076309_2076603 | 0.64 |
MYOM2 |
myomesin 2 |
83272 |
0.11 |
chr6_160490068_160490739 | 0.64 |
IGF2R |
insulin-like growth factor 2 receptor |
15690 |
0.22 |
chrX_107272554_107272719 | 0.64 |
VSIG1 |
V-set and immunoglobulin domain containing 1 |
15564 |
0.19 |
chr9_5301492_5301943 | 0.63 |
RLN2 |
relaxin 2 |
2715 |
0.3 |
chr14_106327072_106327522 | 0.63 |
ENSG00000265714 |
. |
1273 |
0.08 |
chr14_69179227_69179378 | 0.63 |
ENSG00000207089 |
. |
23443 |
0.18 |
chr2_98339483_98339634 | 0.63 |
ZAP70 |
zeta-chain (TCR) associated protein kinase 70kDa |
1775 |
0.34 |
chr9_119452284_119452435 | 0.63 |
TRIM32 |
tripartite motif containing 32 |
2737 |
0.29 |
chr3_71771605_71772061 | 0.63 |
EIF4E3 |
eukaryotic translation initiation factor 4E family member 3 |
2693 |
0.31 |
chr19_30496527_30496720 | 0.63 |
URI1 |
URI1, prefoldin-like chaperone |
3364 |
0.38 |
chr18_56383245_56383396 | 0.63 |
RP11-126O1.4 |
|
36642 |
0.12 |
chr14_50409408_50409559 | 0.63 |
ENSG00000251929 |
. |
40815 |
0.1 |
chr2_204594060_204594283 | 0.63 |
CD28 |
CD28 molecule |
22755 |
0.19 |
chr15_38981829_38982347 | 0.63 |
C15orf53 |
chromosome 15 open reading frame 53 |
6711 |
0.3 |
chr9_92022718_92022899 | 0.63 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
1967 |
0.41 |
chr8_126939819_126940009 | 0.63 |
ENSG00000206695 |
. |
26719 |
0.27 |
chr17_2171475_2171819 | 0.62 |
SMG6 |
SMG6 nonsense mediated mRNA decay factor |
2154 |
0.21 |
chr12_90096202_90096439 | 0.62 |
ATP2B1 |
ATPase, Ca++ transporting, plasma membrane 1 |
6288 |
0.22 |
chr3_190230497_190230722 | 0.62 |
IL1RAP |
interleukin 1 receptor accessory protein |
1231 |
0.58 |
chr4_143491868_143492019 | 0.62 |
INPP4B |
inositol polyphosphate-4-phosphatase, type II, 105kDa |
10121 |
0.33 |
chr12_92793486_92793789 | 0.62 |
RP11-693J15.4 |
|
21670 |
0.18 |
chr10_126437876_126438126 | 0.62 |
FAM53B |
family with sequence similarity 53, member B |
5163 |
0.18 |
chr2_162868937_162869163 | 0.62 |
AC008063.2 |
|
60716 |
0.12 |
chr2_148056205_148056470 | 0.62 |
ENSG00000238860 |
. |
25202 |
0.25 |
chr3_108566035_108566186 | 0.61 |
TRAT1 |
T cell receptor associated transmembrane adaptor 1 |
24491 |
0.23 |
chr5_142602836_142603470 | 0.61 |
ARHGAP26 |
Rho GTPase activating protein 26 |
16388 |
0.24 |
chr14_23014106_23014311 | 0.61 |
AE000662.92 |
Uncharacterized protein |
11326 |
0.1 |
chr2_42456564_42456839 | 0.61 |
AC083949.1 |
|
59260 |
0.12 |
chr5_56145222_56145512 | 0.61 |
ENSG00000238717 |
. |
7608 |
0.16 |
chr14_98440597_98440771 | 0.61 |
C14orf64 |
chromosome 14 open reading frame 64 |
3699 |
0.39 |
chr13_41174871_41175165 | 0.61 |
AL133318.1 |
Uncharacterized protein |
63695 |
0.11 |
chr17_46326518_46326669 | 0.61 |
AC090627.1 |
|
45116 |
0.1 |
chr6_128255998_128256149 | 0.61 |
THEMIS |
thymocyte selection associated |
16297 |
0.26 |
chr2_24437987_24438211 | 0.61 |
AC009228.1 |
|
849 |
0.5 |
chr1_89723727_89724122 | 0.61 |
RP4-620F22.2 |
|
2341 |
0.29 |
chr7_116509392_116509543 | 0.60 |
CAPZA2 |
capping protein (actin filament) muscle Z-line, alpha 2 |
6813 |
0.2 |
chr5_100234027_100234375 | 0.60 |
ST8SIA4 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 |
4717 |
0.33 |
chr1_207508809_207508960 | 0.60 |
CD55 |
CD55 molecule, decay accelerating factor for complement (Cromer blood group) |
13748 |
0.26 |
chr7_144508892_144509461 | 0.60 |
TPK1 |
thiamin pyrophosphokinase 1 |
23970 |
0.23 |
chr1_234536816_234537139 | 0.60 |
COA6 |
cytochrome c oxidase assembly factor 6 homolog (S. cerevisiae) |
27530 |
0.13 |
chr2_171508638_171509172 | 0.60 |
AC007277.3 |
|
8451 |
0.23 |
chr6_143186229_143186520 | 0.60 |
HIVEP2 |
human immunodeficiency virus type I enhancer binding protein 2 |
28190 |
0.23 |
chr1_172349072_172349255 | 0.60 |
DNM3 |
dynamin 3 |
1005 |
0.51 |
chr16_69600802_69601252 | 0.60 |
NFAT5 |
nuclear factor of activated T-cells 5, tonicity-responsive |
773 |
0.53 |
chr2_172176401_172176552 | 0.60 |
METTL8 |
methyltransferase like 8 |
19290 |
0.25 |
chr8_126940439_126940645 | 0.60 |
ENSG00000206695 |
. |
27347 |
0.27 |
chr9_80826413_80826728 | 0.60 |
CEP78 |
centrosomal protein 78kDa |
24408 |
0.22 |
chr1_65342177_65342328 | 0.60 |
JAK1 |
Janus kinase 1 |
89935 |
0.08 |
chr12_92796090_92796306 | 0.60 |
RP11-693J15.4 |
|
19109 |
0.18 |
chr14_100560569_100560771 | 0.59 |
EVL |
Enah/Vasp-like |
2614 |
0.2 |
chr1_231104046_231104197 | 0.59 |
TTC13 |
tetratricopeptide repeat domain 13 |
10421 |
0.14 |
chr2_198065192_198065454 | 0.59 |
ANKRD44 |
ankyrin repeat domain 44 |
2561 |
0.27 |
chr9_67309208_67309388 | 0.59 |
RP11-236F9.2 |
|
24000 |
0.25 |
chr7_50431752_50432472 | 0.59 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
64867 |
0.11 |
chr1_167435126_167435452 | 0.59 |
RP11-104L21.2 |
|
7391 |
0.22 |
chr8_129557036_129557193 | 0.59 |
ENSG00000221351 |
. |
274926 |
0.01 |
chr21_34928117_34928396 | 0.59 |
SON |
SON DNA binding protein |
901 |
0.47 |
chr5_110581595_110581746 | 0.59 |
CAMK4 |
calcium/calmodulin-dependent protein kinase IV |
21886 |
0.19 |
chr15_63961689_63961882 | 0.59 |
RP11-317G6.1 |
|
5560 |
0.21 |
chr1_167471488_167471706 | 0.59 |
CD247 |
CD247 molecule |
16178 |
0.19 |
chr5_40624066_40624286 | 0.59 |
ENSG00000199552 |
. |
30889 |
0.19 |
chr8_132915303_132915585 | 0.59 |
EFR3A |
EFR3 homolog A (S. cerevisiae) |
891 |
0.75 |
chr7_76984255_76984448 | 0.59 |
GSAP |
gamma-secretase activating protein |
24667 |
0.21 |
chr15_101124687_101124838 | 0.59 |
LINS |
lines homolog (Drosophila) |
12379 |
0.13 |
chr6_24842805_24842956 | 0.59 |
ENSG00000263391 |
. |
2587 |
0.27 |
chr1_32377557_32377920 | 0.59 |
AL136115.1 |
HCG2032337; PRO1848; Uncharacterized protein |
1436 |
0.39 |
chr6_166900667_166901285 | 0.59 |
ENSG00000222958 |
. |
21945 |
0.16 |
chr5_141811718_141811869 | 0.58 |
AC005592.2 |
|
28010 |
0.22 |
chr13_50350412_50350563 | 0.58 |
KPNA3 |
karyopherin alpha 3 (importin alpha 4) |
16570 |
0.22 |
chr11_3962507_3962658 | 0.58 |
STIM1 |
stromal interaction molecule 1 |
5991 |
0.18 |
chr1_151876044_151876416 | 0.58 |
THEM4 |
thioesterase superfamily member 4 |
5883 |
0.14 |
chr1_39686834_39687061 | 0.58 |
RP11-416A14.1 |
|
14763 |
0.17 |
chr22_42689321_42689472 | 0.58 |
TCF20 |
transcription factor 20 (AR1) |
50226 |
0.13 |
chr2_106522886_106523037 | 0.58 |
AC009505.2 |
|
49328 |
0.16 |
chr10_33315822_33316332 | 0.58 |
ENSG00000265319 |
. |
7775 |
0.23 |
chr8_126940986_126941137 | 0.58 |
ENSG00000206695 |
. |
27866 |
0.26 |
chr17_47794002_47794247 | 0.58 |
SLC35B1 |
solute carrier family 35, member B1 |
7748 |
0.14 |
chr6_154478833_154479416 | 0.58 |
OPRM1 |
opioid receptor, mu 1 |
71482 |
0.12 |
chr12_120445548_120445820 | 0.58 |
CCDC64 |
coiled-coil domain containing 64 |
18011 |
0.19 |
chr14_98637898_98638078 | 0.58 |
ENSG00000222066 |
. |
160099 |
0.04 |
chr8_42567470_42567887 | 0.58 |
RP11-412B14.1 |
|
9411 |
0.19 |
chr6_130350741_130350892 | 0.57 |
L3MBTL3 |
l(3)mbt-like 3 (Drosophila) |
9114 |
0.29 |
chr5_156966299_156966821 | 0.57 |
AC106801.1 |
|
26412 |
0.14 |
chr19_47028008_47028163 | 0.57 |
PNMAL2 |
paraneoplastic Ma antigen family-like 2 |
28330 |
0.11 |
chr7_32918703_32918854 | 0.57 |
KBTBD2 |
kelch repeat and BTB (POZ) domain containing 2 |
11987 |
0.22 |
chr9_115462031_115462182 | 0.57 |
INIP |
INTS3 and NABP interacting protein |
18281 |
0.21 |
chr2_38816810_38817062 | 0.57 |
HNRNPLL |
heterogeneous nuclear ribonucleoprotein L-like |
10232 |
0.2 |
chr1_198664208_198664359 | 0.57 |
RP11-553K8.5 |
|
28093 |
0.22 |
chr10_126628223_126628374 | 0.57 |
ZRANB1 |
zinc finger, RAN-binding domain containing 1 |
2394 |
0.26 |
chr13_30386101_30386315 | 0.57 |
UBL3 |
ubiquitin-like 3 |
38613 |
0.21 |
chr1_91396393_91396570 | 0.57 |
ZNF644 |
zinc finger protein 644 |
90533 |
0.1 |
chr6_24915197_24915348 | 0.57 |
FAM65B |
family with sequence similarity 65, member B |
4077 |
0.27 |
chr17_37937892_37938188 | 0.57 |
IKZF3 |
IKAROS family zinc finger 3 (Aiolos) |
3562 |
0.18 |
chr1_161031903_161032138 | 0.57 |
AL591806.1 |
Uncharacterized protein |
3635 |
0.1 |
chr8_2080656_2080893 | 0.57 |
MYOM2 |
myomesin 2 |
87590 |
0.1 |
chr12_12633904_12634353 | 0.57 |
DUSP16 |
dual specificity phosphatase 16 |
39931 |
0.17 |
chr4_919824_920024 | 0.56 |
GAK |
cyclin G associated kinase |
6162 |
0.15 |
chr10_70859435_70859586 | 0.56 |
SRGN |
serglycin |
11636 |
0.18 |
chr3_46394034_46394455 | 0.56 |
CCR2 |
chemokine (C-C motif) receptor 2 |
981 |
0.53 |
chr10_120832612_120832844 | 0.56 |
EIF3A |
eukaryotic translation initiation factor 3, subunit A |
7303 |
0.13 |
chr8_129617992_129618163 | 0.56 |
ENSG00000221351 |
. |
213963 |
0.02 |
chr3_195118574_195118757 | 0.56 |
ENSG00000207368 |
. |
21610 |
0.19 |
chr8_42564373_42564748 | 0.56 |
CHRNB3 |
cholinergic receptor, nicotinic, beta 3 (neuronal) |
11998 |
0.18 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 4.3 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
1.0 | 3.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.0 | 5.1 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
1.0 | 3.9 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.8 | 2.4 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.8 | 2.4 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.8 | 2.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.7 | 2.2 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.7 | 2.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.7 | 0.7 | GO:0002666 | T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) |
0.7 | 1.3 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.6 | 2.6 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.6 | 1.8 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.6 | 0.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.6 | 0.6 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.6 | 4.1 | GO:0007172 | signal complex assembly(GO:0007172) |
0.6 | 0.6 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.6 | 1.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.6 | 1.7 | GO:0046137 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.6 | 0.6 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.6 | 1.7 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.6 | 0.6 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.5 | 5.2 | GO:0043368 | positive T cell selection(GO:0043368) |
0.5 | 1.5 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.5 | 1.0 | GO:0001821 | histamine secretion(GO:0001821) |
0.5 | 1.0 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.5 | 1.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.5 | 2.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.5 | 3.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.5 | 1.4 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.5 | 0.9 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.5 | 0.5 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.4 | 2.2 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.4 | 0.9 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.4 | 2.1 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.4 | 0.8 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.4 | 1.7 | GO:2000351 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.4 | 1.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.4 | 3.2 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.4 | 1.2 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.4 | 1.9 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.4 | 1.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.4 | 1.1 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.4 | 9.2 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.3 | 1.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.3 | 0.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.3 | 0.9 | GO:0032506 | cytokinetic process(GO:0032506) |
0.3 | 1.6 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.3 | 0.9 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.3 | 1.2 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.3 | 0.9 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.3 | 0.6 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.3 | 0.9 | GO:0070266 | necroptotic process(GO:0070266) programmed necrotic cell death(GO:0097300) |
0.3 | 0.6 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.3 | 1.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.3 | 0.9 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.3 | 0.6 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.3 | 2.0 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.3 | 0.6 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.3 | 0.3 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.3 | 0.8 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.3 | 0.8 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.3 | 0.5 | GO:1903077 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.3 | 0.8 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.3 | 0.5 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 1.1 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.3 | 1.1 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.3 | 1.6 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.3 | 2.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 2.8 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.3 | 2.3 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.3 | 1.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.3 | 2.0 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.2 | 0.5 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.2 | 0.5 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.2 | 1.7 | GO:0032653 | regulation of interleukin-10 production(GO:0032653) positive regulation of interleukin-10 production(GO:0032733) |
0.2 | 0.7 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.2 | 0.5 | GO:0002507 | tolerance induction(GO:0002507) |
0.2 | 0.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 0.7 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.2 | 0.7 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.2 | 1.7 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 0.2 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.2 | 0.7 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.2 | 0.7 | GO:0010761 | fibroblast migration(GO:0010761) |
0.2 | 0.5 | GO:0048541 | Peyer's patch development(GO:0048541) |
0.2 | 0.7 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.2 | 14.5 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.2 | 0.5 | GO:0002887 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
0.2 | 0.7 | GO:0045056 | transcytosis(GO:0045056) |
0.2 | 0.7 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 1.6 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.2 | 1.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.2 | 0.6 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.2 | 0.6 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.2 | 0.9 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.2 | 0.4 | GO:0051209 | release of sequestered calcium ion into cytosol(GO:0051209) regulation of sequestering of calcium ion(GO:0051282) negative regulation of sequestering of calcium ion(GO:0051283) calcium ion transmembrane import into cytosol(GO:0097553) calcium ion import into cytosol(GO:1902656) |
0.2 | 0.4 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.2 | 0.6 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.2 | 0.8 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.2 | 1.0 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.2 | 0.6 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.2 | 0.8 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 0.2 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.2 | 1.4 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.2 | 1.2 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 0.8 | GO:0002834 | regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) |
0.2 | 0.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.4 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.2 | 1.8 | GO:0030260 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.2 | 0.4 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.2 | 1.6 | GO:0032456 | endocytic recycling(GO:0032456) |
0.2 | 0.2 | GO:0043555 | regulation of translation in response to stress(GO:0043555) regulation of translational initiation in response to stress(GO:0043558) |
0.2 | 0.9 | GO:0019043 | establishment of viral latency(GO:0019043) establishment of integrated proviral latency(GO:0075713) |
0.2 | 0.5 | GO:0071569 | protein ufmylation(GO:0071569) |
0.2 | 0.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.2 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.2 | 1.1 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.2 | 0.5 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.2 | 1.1 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.2 | 0.2 | GO:0051132 | natural killer cell proliferation(GO:0001787) NK T cell activation(GO:0051132) |
0.2 | 0.7 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.7 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.2 | 0.9 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.2 | 0.5 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.2 | 2.0 | GO:0000303 | response to superoxide(GO:0000303) |
0.2 | 0.7 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.2 | 1.8 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.2 | 0.5 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 0.3 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 0.5 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.2 | 1.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.5 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.2 | 0.5 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 0.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 0.5 | GO:0072162 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.2 | 0.5 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.2 | 0.3 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.2 | 0.5 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 0.5 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.2 | 0.5 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.2 | 0.2 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.2 | 3.7 | GO:0006997 | nucleus organization(GO:0006997) |
0.2 | 0.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.8 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.2 | 0.2 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 0.4 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.7 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.1 | GO:0017085 | response to insecticide(GO:0017085) |
0.1 | 0.7 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.1 | 0.4 | GO:0001743 | optic placode formation(GO:0001743) |
0.1 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.3 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.3 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.1 | GO:0071803 | regulation of podosome assembly(GO:0071801) positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.9 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.3 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.1 | 0.3 | GO:0050685 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.1 | 1.3 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 | 0.3 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 0.4 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.3 | GO:0000090 | mitotic anaphase(GO:0000090) |
0.1 | 0.1 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.4 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.3 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.1 | 0.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.9 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.3 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.3 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.3 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.1 | 0.5 | GO:1902305 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.1 | 0.4 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.1 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.8 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.5 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.5 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.1 | 1.9 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.4 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.3 | GO:2000144 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 1.6 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 1.4 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.4 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.1 | 0.1 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.1 | 0.2 | GO:0046958 | nonassociative learning(GO:0046958) |
0.1 | 0.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 2.0 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.1 | 0.7 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.1 | 0.5 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 1.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.6 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.1 | GO:0031223 | auditory behavior(GO:0031223) |
0.1 | 0.2 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 1.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.4 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.6 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.5 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.1 | 0.1 | GO:0019049 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 | 0.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.7 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.1 | 0.6 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.8 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.2 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.1 | 0.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.4 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.2 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.5 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 2.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.6 | GO:0015904 | tetracycline transport(GO:0015904) |
0.1 | 0.2 | GO:0051459 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) mucosal immune response(GO:0002385) |
0.1 | 0.5 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.1 | 0.5 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.5 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.1 | 0.5 | GO:0033483 | gas homeostasis(GO:0033483) |
0.1 | 0.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.8 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.3 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.1 | 0.3 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 1.4 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 0.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.1 | GO:0015851 | nucleobase transport(GO:0015851) |
0.1 | 0.3 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 1.5 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 1.1 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.1 | 0.4 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.7 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 0.3 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.1 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.1 | 0.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 1.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.1 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.1 | 0.5 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.1 | 0.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.3 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.1 | 0.2 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.3 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.1 | 0.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.3 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.1 | 0.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.2 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.1 | 0.3 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.3 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 2.4 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 1.4 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.8 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.4 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.1 | 0.3 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.1 | GO:2001259 | positive regulation of calcium ion transmembrane transporter activity(GO:1901021) positive regulation of cation channel activity(GO:2001259) |
0.1 | 0.6 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.1 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.1 | 0.1 | GO:0032747 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 1.2 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.1 | 0.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.6 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.2 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.8 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.1 | GO:0052306 | pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response(GO:0052033) positive regulation by symbiont of host innate immune response(GO:0052166) modulation by symbiont of host innate immune response(GO:0052167) pathogen-associated molecular pattern dependent modulation by symbiont of host innate immune response(GO:0052169) pathogen-associated molecular pattern dependent induction by organism of innate immune response of other organism involved in symbiotic interaction(GO:0052257) positive regulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052305) modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052306) pathogen-associated molecular pattern dependent modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052308) |
0.1 | 2.5 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.4 | GO:0070265 | necrotic cell death(GO:0070265) |
0.1 | 0.2 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 1.1 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.3 | GO:0031529 | ruffle organization(GO:0031529) |
0.1 | 0.1 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.4 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.1 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.1 | 0.3 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 0.1 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.1 | 1.9 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.1 | 0.8 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.1 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.1 | 0.8 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.3 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.1 | 0.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.6 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 6.8 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.7 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.2 | GO:0019730 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
0.1 | 0.3 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.1 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.2 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 1.2 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.1 | 1.0 | GO:0000097 | sulfur amino acid biosynthetic process(GO:0000097) |
0.1 | 0.3 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.4 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.1 | 0.2 | GO:0048488 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.2 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) |
0.1 | 0.4 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.1 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.1 | 0.2 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.1 | 0.3 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.2 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 1.3 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 4.1 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.3 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.1 | 1.3 | GO:0000045 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.1 | 0.1 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.1 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.1 | 0.2 | GO:0072074 | kidney mesenchyme development(GO:0072074) metanephric mesenchyme development(GO:0072075) |
0.1 | 0.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 1.7 | GO:0090317 | negative regulation of intracellular protein transport(GO:0090317) |
0.1 | 0.2 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 0.4 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.7 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 0.1 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.1 | 0.2 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.2 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.1 | 1.0 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.1 | GO:0048278 | vesicle docking(GO:0048278) |
0.1 | 0.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.5 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 0.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.8 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.2 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.1 | 1.6 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.5 | GO:0001662 | behavioral fear response(GO:0001662) |
0.1 | 0.2 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.4 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.1 | 0.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 2.9 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.1 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.1 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.1 | 0.3 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.6 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.1 | 0.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.1 | 0.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.2 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 0.3 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.1 | 0.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 1.3 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.1 | 0.1 | GO:0060433 | bronchus development(GO:0060433) |
0.1 | 0.2 | GO:0035610 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.1 | 0.1 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.1 | 0.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 8.2 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.1 | 1.2 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.1 | 0.2 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 0.3 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.2 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.1 | 0.6 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.2 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.1 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.1 | 0.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.3 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.1 | GO:0002031 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) G-protein coupled receptor internalization(GO:0002031) negative adaptation of signaling pathway(GO:0022401) adaptation of signaling pathway(GO:0023058) |
0.1 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 1.2 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 0.3 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 0.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 1.0 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.1 | 3.6 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 0.2 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.7 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.6 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.5 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.3 | GO:0021561 | facial nerve development(GO:0021561) |
0.1 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.3 | GO:0002921 | negative regulation of humoral immune response(GO:0002921) negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.1 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.4 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.1 | 0.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.2 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.1 | 0.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.3 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.1 | 0.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 1.8 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.1 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.1 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 0.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.3 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.1 | 0.2 | GO:0021683 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.2 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 1.0 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 0.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.7 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.1 | 0.2 | GO:0042117 | monocyte activation(GO:0042117) |
0.1 | 0.1 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 0.3 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.1 | 0.1 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.1 | 0.1 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 0.2 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.1 | 0.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 1.0 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.1 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.1 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.1 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.1 | 1.3 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.1 | 0.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.8 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.1 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.1 | 0.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.3 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.1 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.1 | 0.1 | GO:0043489 | RNA stabilization(GO:0043489) mRNA stabilization(GO:0048255) |
0.1 | 0.4 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 1.0 | GO:0035036 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
0.1 | 0.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.1 | 0.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 2.5 | GO:0007498 | mesoderm development(GO:0007498) |
0.1 | 0.1 | GO:0000966 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) cleavage involved in rRNA processing(GO:0000469) endonucleolytic cleavage involved in rRNA processing(GO:0000478) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) RNA 5'-end processing(GO:0000966) RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.4 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.1 | 0.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.1 | 0.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.2 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 1.9 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.1 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
0.1 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.1 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.6 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.1 | 0.1 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.4 | GO:0000050 | urea cycle(GO:0000050) |
0.1 | 0.3 | GO:0051298 | centrosome duplication(GO:0051298) |
0.1 | 0.1 | GO:0060235 | olfactory placode formation(GO:0030910) lens induction in camera-type eye(GO:0060235) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.1 | 2.5 | GO:2000134 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 0.2 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.1 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.5 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.1 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.1 | 1.1 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 5.3 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.1 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 0.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.1 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.1 | 0.1 | GO:0072141 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) pericyte cell differentiation(GO:1904238) |
0.1 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.1 | 0.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.1 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.1 | 0.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.1 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.1 | 2.3 | GO:0097194 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) execution phase of apoptosis(GO:0097194) |
0.1 | 0.2 | GO:0015853 | adenine transport(GO:0015853) |
0.1 | 0.2 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.1 | 0.3 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.1 | 0.5 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.1 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.2 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.4 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.1 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.0 | 0.3 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.3 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.1 | GO:0072698 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.0 | 0.1 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.0 | 0.2 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.0 | 0.0 | GO:0046386 | deoxyribose phosphate catabolic process(GO:0046386) |
0.0 | 0.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.7 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 1.3 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.0 | 0.2 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.3 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.0 | 0.1 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.0 | 0.1 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.2 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.0 | 0.1 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.0 | 0.0 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.0 | 0.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.3 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.0 | 0.5 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.4 | GO:0051017 | actin filament bundle assembly(GO:0051017) actin filament bundle organization(GO:0061572) |
0.0 | 0.1 | GO:0045079 | negative regulation of chemokine production(GO:0032682) negative regulation of chemokine biosynthetic process(GO:0045079) |
0.0 | 0.1 | GO:0044766 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.0 | 0.3 | GO:0034372 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.0 | 0.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.0 | GO:0046083 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.0 | 0.3 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.0 | 0.1 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.4 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 0.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.4 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.0 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.0 | 0.1 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.0 | 0.0 | GO:0000239 | pachytene(GO:0000239) |
0.0 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.0 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.0 | 0.1 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 1.1 | GO:0033572 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.2 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.5 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.0 | GO:0044068 | modulation by virus of host process(GO:0019054) modulation by virus of host gene expression(GO:0039656) modulation by symbiont of host cellular process(GO:0044068) |
0.0 | 0.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 1.1 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.1 | GO:0034764 | positive regulation of transmembrane transport(GO:0034764) positive regulation of ion transmembrane transport(GO:0034767) |
0.0 | 0.2 | GO:0030277 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.2 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.0 | 0.0 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.0 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.1 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.2 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 0.9 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.0 | 0.1 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.5 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.5 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.0 | 0.4 | GO:0006949 | syncytium formation(GO:0006949) |
0.0 | 0.0 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.0 | 1.3 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.0 | 0.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.3 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.4 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.5 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.0 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.2 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.3 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.0 | 0.2 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.0 | 0.2 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 1.5 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.0 | GO:2000300 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.2 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.0 | 0.3 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.0 | 0.2 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.0 | 0.1 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.0 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.2 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.1 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.0 | 0.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.3 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.0 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.4 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.0 | GO:1901072 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.1 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
0.0 | 0.3 | GO:0034765 | regulation of ion transmembrane transport(GO:0034765) |
0.0 | 0.1 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.0 | 1.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.0 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.1 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.0 | 0.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.3 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.6 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.0 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.4 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.0 | GO:0050879 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
0.0 | 0.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.0 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.0 | 0.0 | GO:0034121 | regulation of toll-like receptor signaling pathway(GO:0034121) |
0.0 | 0.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.2 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.0 | 0.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.0 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.0 | 0.1 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.0 | 1.0 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.1 | GO:0070293 | renal absorption(GO:0070293) |
0.0 | 0.1 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 0.7 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.0 | 0.1 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.0 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.1 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.0 | 0.3 | GO:0048880 | sensory system development(GO:0048880) lateral line nerve development(GO:0048892) lateral line nerve glial cell differentiation(GO:0048895) lateral line system development(GO:0048925) lateral line nerve glial cell development(GO:0048937) iridophore differentiation(GO:0050935) |
0.0 | 0.1 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.0 | 0.1 | GO:0021702 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.2 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.0 | 0.2 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 0.1 | GO:1904950 | negative regulation of establishment of protein localization(GO:1904950) |
0.0 | 0.7 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.0 | 0.7 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.5 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.1 | GO:0072111 | cell proliferation involved in kidney development(GO:0072111) |
0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.1 | GO:0016236 | macroautophagy(GO:0016236) |
0.0 | 0.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 2.0 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.0 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.2 | GO:0098930 | axonal transport(GO:0098930) |
0.0 | 0.0 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.0 | 0.1 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.0 | 0.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.5 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.0 | 0.0 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.1 | GO:1903319 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.0 | 0.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.0 | 0.2 | GO:0043586 | tongue development(GO:0043586) |
0.0 | 0.7 | GO:0042384 | cilium assembly(GO:0042384) |
0.0 | 0.6 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.1 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.0 | 3.0 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.0 | 0.1 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.0 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) negative regulation of thymocyte apoptotic process(GO:0070244) |
0.0 | 0.0 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.0 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.0 | 0.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 0.2 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.4 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.1 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.0 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.0 | 0.2 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.0 | 0.1 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.0 | 0.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.1 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.6 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.1 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.0 | 0.1 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 0.2 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.2 | GO:0006101 | citrate metabolic process(GO:0006101) |
0.0 | 0.1 | GO:0010984 | regulation of lipoprotein particle clearance(GO:0010984) |
0.0 | 0.1 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.0 | 0.0 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.0 | 0.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.0 | GO:1903828 | negative regulation of cellular protein localization(GO:1903828) |
0.0 | 0.3 | GO:0030835 | regulation of actin filament depolymerization(GO:0030834) negative regulation of actin filament depolymerization(GO:0030835) actin filament capping(GO:0051693) |
0.0 | 0.3 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.3 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.0 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
0.0 | 0.0 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.0 | 0.3 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 2.3 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.7 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.0 | GO:0015872 | dopamine transport(GO:0015872) |
0.0 | 0.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.0 | 0.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 6.4 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.0 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.0 | 1.9 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.1 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.3 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.3 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.0 | 0.2 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.0 | 0.0 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.0 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.3 | GO:0006323 | DNA packaging(GO:0006323) |
0.0 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.0 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.0 | 0.1 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.0 | 0.0 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.0 | 0.0 | GO:0072498 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.0 | 0.2 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.0 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.0 | 0.0 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.0 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.0 | 0.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.1 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
0.0 | 0.1 | GO:0070193 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
0.0 | 0.0 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.0 | 0.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.0 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 1.7 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0010458 | exit from mitosis(GO:0010458) |
0.0 | 0.1 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.2 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.0 | 0.3 | GO:0021549 | cerebellum development(GO:0021549) |
0.0 | 0.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.1 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.0 | 0.0 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.0 | 0.0 | GO:0003094 | regulation of glomerular filtration(GO:0003093) glomerular filtration(GO:0003094) renal filtration(GO:0097205) regulation of renal system process(GO:0098801) |
0.0 | 0.0 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.0 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.0 | 0.0 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.0 | 0.0 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.0 | 0.0 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.0 | GO:0045821 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.0 | 0.0 | GO:1901160 | serotonin metabolic process(GO:0042428) primary amino compound metabolic process(GO:1901160) |
0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.3 | GO:0072655 | protein targeting to mitochondrion(GO:0006626) establishment of protein localization to mitochondrion(GO:0072655) |
0.0 | 0.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:0007632 | visual behavior(GO:0007632) |
0.0 | 1.9 | GO:0006511 | ubiquitin-dependent protein catabolic process(GO:0006511) |
0.0 | 0.1 | GO:0010608 | posttranscriptional regulation of gene expression(GO:0010608) |
0.0 | 0.0 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 0.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.0 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.2 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.0 | 0.0 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.1 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.0 | 0.0 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.0 | 0.1 | GO:0006561 | proline metabolic process(GO:0006560) proline biosynthetic process(GO:0006561) |
0.0 | 0.0 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.0 | 0.2 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.1 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.0 | GO:0034698 | response to gonadotropin(GO:0034698) |
0.0 | 0.0 | GO:0010042 | response to manganese ion(GO:0010042) |
0.0 | 0.1 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.1 | GO:0046849 | bone remodeling(GO:0046849) |
0.0 | 0.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.0 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.0 | GO:0002063 | chondrocyte development(GO:0002063) |
0.0 | 0.0 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.0 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.0 | 0.0 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.0 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.6 | 2.4 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.5 | 4.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 1.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.4 | 1.2 | GO:0072487 | MSL complex(GO:0072487) |
0.4 | 1.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.3 | 4.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 1.3 | GO:0005827 | polar microtubule(GO:0005827) |
0.3 | 3.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 0.3 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.3 | 0.9 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.3 | 0.8 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.3 | 0.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 2.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 2.8 | GO:0045120 | pronucleus(GO:0045120) |
0.3 | 0.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 0.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 3.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 2.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 1.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 0.9 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.2 | 0.7 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 0.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 1.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 1.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 7.0 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 1.9 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 1.1 | GO:0000791 | euchromatin(GO:0000791) |
0.2 | 0.2 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.2 | 0.9 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 1.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 2.5 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 2.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 0.7 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 1.7 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.2 | 0.5 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 1.0 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 0.5 | GO:0001652 | granular component(GO:0001652) |
0.2 | 0.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 1.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.2 | 1.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 1.6 | GO:0032156 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.1 | 3.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.8 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 1.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.3 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 2.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.7 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 2.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.6 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 4.0 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.5 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 2.0 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.1 | 0.1 | GO:0033646 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.5 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 1.0 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.5 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 1.4 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 1.0 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 2.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.6 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.5 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.6 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 1.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.4 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.3 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.6 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.2 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 0.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 8.3 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.3 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 1.0 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 1.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.3 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.1 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.1 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.1 | 0.8 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) anaphase-promoting complex(GO:0005680) |
0.1 | 3.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.7 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.2 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.3 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 0.3 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 1.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.3 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 1.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.1 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.1 | 0.6 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 1.3 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 2.2 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.1 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.2 | GO:0070938 | actomyosin contractile ring(GO:0005826) contractile ring(GO:0070938) |
0.1 | 0.7 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.4 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 3.2 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) platelet dense granule(GO:0042827) |
0.1 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.3 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.4 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 0.3 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.4 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.1 | 0.3 | GO:0033011 | perinuclear theca(GO:0033011) |
0.1 | 0.8 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 1.5 | GO:0034708 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.1 | 2.0 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.4 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) |
0.1 | 0.3 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.1 | 0.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 3.8 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.2 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.7 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 4.2 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.4 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.5 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 2.3 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.2 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.1 | 0.5 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.3 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 7.1 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 0.3 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 0.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.9 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 2.7 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.2 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.8 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 5.1 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 0.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 5.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.1 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.1 | 0.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.4 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.8 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.2 | GO:0031672 | A band(GO:0031672) |
0.1 | 5.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.2 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.0 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 1.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.2 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.0 | 0.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.0 | GO:0009295 | nucleoid(GO:0009295) |
0.0 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.8 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 1.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.2 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.0 | 2.2 | GO:0016604 | nuclear body(GO:0016604) |
0.0 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.4 | GO:0042597 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.0 | 0.6 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.0 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.3 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 1.8 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 1.3 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 1.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 29.2 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 1.8 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.4 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 1.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.3 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.0 | 0.1 | GO:0042825 | TAP complex(GO:0042825) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.2 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.5 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.0 | 0.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0038201 | TORC1 complex(GO:0031931) TOR complex(GO:0038201) |
0.0 | 0.7 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.3 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.4 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.0 | 0.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 3.2 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 0.1 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 7.4 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.5 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 9.0 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.6 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.4 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.0 | 11.1 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.0 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.3 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 58.3 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 3.9 | GO:0019866 | organelle inner membrane(GO:0019866) |
0.0 | 1.5 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.9 | GO:0019867 | outer membrane(GO:0019867) |
0.0 | 0.0 | GO:0031083 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.0 | 3.3 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.2 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 1.8 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.7 | 2.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.7 | 2.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.6 | 2.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.6 | 8.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.6 | 2.8 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.5 | 4.9 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.5 | 1.5 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.5 | 1.8 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.4 | 1.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 4.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.4 | 0.4 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.4 | 2.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.4 | 1.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.3 | 1.0 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.3 | 2.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 0.9 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 2.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 0.6 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.3 | 1.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.3 | 0.8 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.3 | 0.5 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 0.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 2.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.3 | 2.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 1.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 1.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.3 | 1.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 1.5 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 0.7 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 5.7 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 0.7 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.2 | 0.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 1.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 2.8 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 3.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 1.8 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 0.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 0.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 1.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 3.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 0.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 2.9 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 1.2 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 1.6 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 0.8 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.2 | 0.6 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.2 | 0.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 0.8 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.2 | 0.6 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.2 | 0.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 0.7 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 0.9 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 0.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 2.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 2.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 4.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 1.8 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.2 | 0.9 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 1.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 6.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 0.7 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.2 | 1.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.2 | 0.5 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.2 | 1.5 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.2 | 2.8 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.2 | 0.5 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.2 | 1.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.2 | 0.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 5.7 | GO:0036459 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 1.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 1.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.5 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 0.3 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.2 | 0.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 0.5 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.6 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.4 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 0.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 0.4 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.7 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 1.3 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 3.9 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 1.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 6.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.6 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.4 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 1.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.4 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.3 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.4 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 7.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 1.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 1.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.8 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.8 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 1.8 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.9 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.8 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 1.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.4 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.1 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.8 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 2.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 1.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.4 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.5 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.6 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.9 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 1.8 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 1.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.1 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.1 | 0.3 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 0.9 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.6 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.1 | 2.0 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.8 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.9 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.3 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 1.9 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.6 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.9 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.5 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.6 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 2.8 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 1.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.3 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 1.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.4 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.5 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.1 | 1.0 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.1 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.1 | 0.8 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 2.5 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.5 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.1 | 0.7 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 1.3 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.1 | 0.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 1.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 2.1 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.6 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 4.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.4 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.4 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.7 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 1.9 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.1 | 2.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.3 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.1 | 1.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.2 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 0.2 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.4 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.1 | 1.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 1.1 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.2 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.2 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 0.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 2.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 1.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.4 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.1 | 0.9 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.1 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.1 | 0.1 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.7 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.1 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.1 | 0.1 | GO:0019959 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.1 | 0.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.3 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.1 | 0.3 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.1 | 0.2 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 0.1 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.3 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 6.5 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.2 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 0.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 2.2 | GO:0008137 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 1.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.1 | GO:0032558 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 1.1 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.4 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.3 | GO:0004396 | hexokinase activity(GO:0004396) |
0.1 | 1.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 2.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.1 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 0.3 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 0.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.3 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
0.1 | 0.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.6 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 1.3 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.4 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.3 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.1 | 0.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.1 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.1 | 0.8 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.4 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 0.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.3 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.1 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 25.8 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.4 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.0 | 3.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.1 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.3 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.2 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 1.9 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.1 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.2 | GO:0015923 | mannosidase activity(GO:0015923) |
0.0 | 0.2 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 1.4 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
0.0 | 1.4 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.0 | 0.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.5 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.6 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.0 | 0.2 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 1.3 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.4 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.1 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 1.7 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.6 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.0 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 2.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.2 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.0 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.3 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.0 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.0 | 1.0 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 7.1 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.8 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.2 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.0 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.9 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.1 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.0 | 0.6 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.0 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.0 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.0 | 0.1 | GO:0080031 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 1.9 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.3 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.6 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.6 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.2 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 8.0 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.0 | 0.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.0 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.0 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.2 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.5 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 0.3 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.9 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 2.2 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.0 | 0.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.2 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.6 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.0 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.0 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.0 | GO:0051192 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.0 | 0.7 | GO:0044389 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.1 | GO:0001228 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.4 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.8 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.0 | 1.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.1 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.0 | 0.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.0 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 0.0 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 0.3 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.6 | GO:0019829 | cation-transporting ATPase activity(GO:0019829) |
0.0 | 0.5 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.3 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 1.5 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 4.8 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.1 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.0 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.0 | 29.1 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.0 | 0.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 1.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.0 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.0 | 0.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.5 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.0 | 0.0 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.0 | 0.2 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.1 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.3 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.1 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) glucosyltransferase activity(GO:0046527) |
0.0 | 0.1 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.0 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.0 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.0 | GO:0070568 | RNA guanylyltransferase activity(GO:0008192) guanylyltransferase activity(GO:0070568) |
0.0 | 0.0 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 0.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.0 | 0.1 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 29.3 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 3.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 1.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.3 | 8.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 2.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 5.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 12.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.3 | 2.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 6.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 0.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 2.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 2.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 1.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 1.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 4.3 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 2.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 4.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 2.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 5.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 7.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 3.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 3.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 4.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.8 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 1.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 1.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 4.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.8 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 1.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 4.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 2.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 1.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 3.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 3.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 1.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 1.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 1.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 2.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 1.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.5 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 1.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.0 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.5 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.3 | PID P73PATHWAY | p73 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 1.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.7 | 7.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.5 | 26.3 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.4 | 1.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 4.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 5.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 3.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.3 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 2.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 3.6 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 4.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 4.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 3.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 4.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 1.7 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 3.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 0.8 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 7.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 3.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 1.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 1.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 3.8 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.2 | 3.6 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.2 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 3.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 7.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 2.6 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 2.0 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 1.7 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 2.9 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 4.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.6 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 1.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 0.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 2.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 0.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 0.4 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 0.7 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 1.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.8 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 1.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.2 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.1 | 0.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 2.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 1.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 1.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.2 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 0.5 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 1.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 1.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 1.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 0.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 1.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 7.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 1.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 1.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 0.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.3 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 0.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 1.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 5.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 3.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.0 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 1.1 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.3 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 2.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 1.9 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 0.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 0.2 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 1.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 1.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.8 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 3.3 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 0.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 2.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 1.4 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 0.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 2.6 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 0.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.1 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.1 | 2.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 2.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.1 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.1 | 0.4 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 7.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.9 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 1.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.4 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 1.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.1 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.1 | 0.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 0.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.1 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 3.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 2.0 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.0 | 2.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 2.1 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.7 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.7 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 1.9 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.0 | 0.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.5 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.0 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.1 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.0 | 0.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.1 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 1.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.1 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.0 | 0.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.0 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 1.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.0 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 5.8 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.2 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.0 | 0.0 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 0.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.1 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.0 | 0.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.3 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.0 | 0.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.0 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.0 | 0.3 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.0 | 0.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |